In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Collegium Pharmaceutical, Inc.. Trade Record

NASDAQ:COLL Collegium Pharmaceutical, Inc. stock gains 6.88% Exit Jul 5, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart COLL Jun 19, 2019, priceSeries
About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. It offers Xtampza, an oral formulation of oxycodone, for the management of pain. The company also develops Onsolis, a transmucosal immediate-release fentanyl film indicated for the management of breakthrough pain in cancer patients 18 years of age and older. The company is also developing COL-195, a hydrocodone for the treatment of chronic pain; COL-172, an oxymorphone for the treatment of chronic pain; COL-196, a morphine formulation to treat pain; and COL-171, a methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.

Trade Information
Trade Type
Entry Date
Jun 19, 2019
Entry Price
Sell Date
Jul 5, 2019
Sell Price
Net Gain
Hold Time
11 Trading Days